Skip to main content
Search

Karolinska Institutet

8 related articles

Subscribe to updates
  1. bioRxiv

    Neighbor transcripts leak into spatial cells: DisCell splits spillover from niche response and gives each finding a breakdown point

    Single-cell spatial transcriptomics counts neighboring cells' transcripts inside a cell, and this spillover and a cell's real response to its niche both tie expression to surroundings, so counts alone cannot separate them. DisCell models intrinsic state, niche response and spillover jointly, refits over a range of spillover fractions, and assigns each finding a breakdown point. On ovarian and lung sections its intrinsic state keeps more cell-cycle information than any competing method holding as little neighborhood information, and a published esophageal EMT finding survives the modeled spillover range.

  2. Nature Methods

    Cell segmentation in spatial transcriptomics gets a cross-platform test: SAM tops the raw score, SCS leads once coverage counts

    Cell segmentation in spatial transcriptomics has lacked a cross-platform comparison with biologically meaningful metrics. A benchmark evaluates 11 image-based, transcriptomics-based and multimodal methods across 15 datasets from 5 technologies and about 2.3 million cells, scoring segmentation quality, transcript recovery, morphology, expression purity and spatial organization. On the average of 15 metrics, SAM scores highest (0.58), ahead of SAM2 (0.53), BIDCell (0.52) and SCS (0.48); after adjusting by the ratio of segmented to reference cells, SCS leads (0.34), with BIDCell and Baysor both at 0.33.

  3. Joint multi-sample network inference steadies omics reconstructions, but a prior cut to 20% leaves zero active reactions

    Multi-sample regulatory network inference has long solved each sample separately and stitched shared structure from overlaps, which is unstable under noise. CORNETO instead solves several samples inside one mixed-integer constrained optimization with structured sparsity penalties. On haematopoietic and adult cortical single-cell data, joint inference generally improved robustness and reproducibility, while predictive gains depended on biological context and prior-network completeness.

  4. arXiv

    S3N pairs finite-element LL–HP mapping with quad-spiral state-space scanning to cut 10-day forecast nRMSE to 0.5177

    The work proposes S3N, a spherical spiral scanning network that uses the surface finite-element L2Proj method to bidirectionally map atmospheric fields between the latitude–longitude grid and the equal-area HEALPix grid, and an Attention-Guided Quad-Spiral State-Space Scanning block that propagates information across HEALPix base-face boundaries along four global pole-to-pole spiral paths guided by cross-latitude attention; on ERA5/WeatherBench 2, S3N attains lower nRMSE at 4-, 7-, and 10-day lead times (0.5177 at 10 days versus 0.6398 for OneForecast) with slower error growth, while being less competitive at 6-hour and 1-day lead times.

  5. A 45-member modified Delphi consensus: screen for eating disorders before GLP-1 receptor agonist prescribing, and generally avoid these agents in active anorexia and bulimia nervosa

    Using a three-round modified Delphi method, a 45-member panel of clinicians and researchers in diabetes, obesity and/or eating disorders plus people with lived experience reached an average 91.7% consensus on recommendations for GLP-1 receptor agonist use in eating disorder contexts, covering pre-treatment screening, risk-stratified monitoring, standardized educational materials and concurrent evidence-based psychotherapy, stating that these agents should generally be avoided in active eating disorders, particularly anorexia nervosa, atypical anorexia nervosa and bulimia nervosa with marked dietary restraint and/or significant weight suppression, and setting out research priorities in epidemiology, regulation and binge eating disorder trials.

  6. arXiv

    TT-VidT splits appearance and motion into two pathways: among 24 architecture-objective pairings, only TT3D with Diff Compression leads Jester, SSv2, ARID and Diving48 at once

    The work proposes TT-VidT, which pairs a DINOv3-initialized ViT-B/16 per-frame spatial path with a compact Temporal Transfer Layer and trains it by Diff Compression to reconstruct target frames from a first-frame appearance anchor and frame-specific motion tokens; under a matched recipe at roughly 170M-190M encoder scale on 1.7M OpenVid and Moments-in-Time v2 clips for 8 epochs, a 24-cell architecture-objective sweep shows that only TT3D with Diff Compression enters the strongest motion-sensitive regime, and in the final comparison it leads Jester, Something-Something V2, ARID and Diving48 fine-tuning simultaneously while using 48% fewer encoder FLOPs than DisMo and 55% fewer than VideoMAE or V-JEPA 2.

  7. Review proposes a microbiome-aware oral formulation framework: excipient risk classification, nanocarrier design rules, and a tiered testing roadmap

    This review integrates evidence on microbial drug metabolism, excipient–microbiome interactions, nanocarrier–microbiome interfaces, microbiota-responsive release mechanisms, and experimental models to propose an authors' evidence-informed framework for oral formulation design, comprising an excipient–microbiome risk classification, nanocarrier design rules, microbiota-responsive delivery decision logic, and a tiered testing roadmap, illustrated by clinically relevant examples such as digoxin inactivation by Eggerthella lenta, bacterial levodopa metabolism, and microbial beta-glucuronidase-mediated irinotecan toxicity.

  8. Nature News

    Human-supervised Agentic AI for Hypothesis Generation and Experimental Assistance in Drug Repurposing

    The study developed RepurAgent, a hierarchical multi-agent AI system in which a supervisor agent and a planning agent coordinate four specialized sub-agents (research, prediction, data, and report) through a human-in-the-loop design with episodic memory and retrieval-augmented generation, and validated it across three scenarios spanning the drug repurposing lifecycle: in Acute Myeloid Leukemia a blinded expert evaluation indicated substantially more novel and mechanistically credible candidates than a vanilla LLM baseline; in a retrospective COVID-19 antiviral screen it prioritized compounds with AUC-ROC up to 0.

You’re all caught up